(Q40031389)

English

Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects

scientific article published on November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Jean-Francois Marier

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Martin Beliveau

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Mohamad-Samer Mouksassi

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Paula Shaw

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jane Cyran

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Jothi Kesavan

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

John Wallens

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hamim Zahir

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

David Wells

9

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

John Caminis

10

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1289-1299

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Review article: glucagon-like peptide 2--current applications and future directions

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Teduglutide for the treatment of short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Review article: medical treatment of active Crohn's disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Management of Crohn's disease in adults

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Confidence interval criteria for assessment of dose proportionality.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Transaminase elevation on placebo during phase I trials: prevalence and significance

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Biologic therapy of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Structural determinants for activity of glucagon-like peptide-2.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008320605

21 January 2018

Identifiers

10.1177/0091270008320605

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

release_u7c74d75o5cejlzqwfha77rzem

1 reference

https://api.fatcat.wiki/v0/release/u7c74d75o5cejlzqwfha77rzem

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40031389&oldid=2143519817"